These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 35955767
1. Hydrogen Sulfide and Substance P Levels in Patients with Escherichia coli and Klebsiella pneumoniae Bacteraemia. Manandhar S, Scott-Thomas A, Harrington M, Sinha P, Pilbrow A, Richards AM, Cameron V, Bhatia M, Chambers ST. Int J Mol Sci; 2022 Aug 03; 23(15):. PubMed ID: 35955767 [Abstract] [Full Text] [Related]
3. Epidemiology of Klebsiella bacteraemia: a case control study using Escherichia coli bacteraemia as control. Hansen DS, Gottschau A, Kolmos HJ. J Hosp Infect; 1998 Feb 03; 38(2):119-32. PubMed ID: 9522290 [Abstract] [Full Text] [Related]
6. Risk factors for 28-day mortality in elderly patients with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia. Ku NS, Kim YC, Kim MH, Song JE, Oh DH, Ahn JY, Kim SB, Kim HW, Jeong SJ, Han SH, Kim CO, Song YG, Kim JM, Choi JY. Arch Gerontol Geriatr; 2014 Feb 03; 58(1):105-9. PubMed ID: 23988261 [Abstract] [Full Text] [Related]
7. The effect of preoperative urine culture and bacterial species on infection after percutaneous nephrolithotomy for patients with upper urinary tract stones. Yang Z, Lin D, Hong Y, Hu M, Cai W, Pan H, Li Q, Lin J, Ye L. Sci Rep; 2022 Mar 22; 12(1):4833. PubMed ID: 35318408 [Abstract] [Full Text] [Related]
8. [Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection]. Chen YH, Yao WZ, Wu R, Zhou QT, Liu ZY, Zhang XW. Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov 22; 31(11):815-9. PubMed ID: 19080534 [Abstract] [Full Text] [Related]
9. Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospective study. Lee CH, Su LH, Chen FJ, Tang YF, Li CC, Chien CC, Liu JW. Int J Antimicrob Agents; 2015 Dec 22; 46(6):610-5. PubMed ID: 26387064 [Abstract] [Full Text] [Related]
10. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia. Ben-Chetrit E, Eldaim MA, Bar-Meir M, Dodin M, Katz DE. Int J Antimicrob Agents; 2019 Apr 22; 53(4):423-428. PubMed ID: 30572008 [Abstract] [Full Text] [Related]